Delivering Therapeutics Through The Blood Brain Barrier Could Lead To Better Treatment of Central Nervous System Disorders

Friday, Aug. 23rd 2013 8:10 AM

The treatment of central nervous system (CNS) diseases can be particularly challenging because many of the therapeutic agents such as recombinant proteins and gene medicines are not easily transported across the blood-brain barrier (BBB). Focused ultrasound can be used to “open the door” of the blood brain barrier.

Posted on Friday, Aug. 23rd 2013 8:10 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.